MTHFD2 marks pemetrexed resistance in pulmonary adenocarcinoma with EGFR wild type.
MTHFD2 是 EGFR 野生型肺腺癌中培美曲塞耐药性的标志
期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-02355-z
Yao Sha, Elakad Omar, Yang Xiang Hui, Altaf Adnan Raza, Yu Wen Tao, Bohnenberger Hanibal, Peng Luo Gen
